Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (181-190 of 353) with videos related to

Pageof 36
Sort By:
JAMA Network Open|October 27, 2023
Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical TrialKarol M Pencina, Thomas G Travison, Andrew S Artz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2002
Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human studyEli I Lev, Jonathan D Marmur, Milan Zdravkovic, et al.
The Journal of Clinical Endocrinology and Metabolism|January 11, 2024
Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement TherapyShalender Bhasin, Stuart Seidman, Thomas G Travison, et al.
Circulation|November 26, 2009
Smoking, clopidogrel, and mortality in patients with established cardiovascular diseaseJeffrey S Berger, Deepak L Bhatt, Steven R Steinhubl, et al.
The American Journal of Cardiology|May 3, 2011
Comparison of outcomes of unprotected left main versus multivessel coronary artery interventionsShikhar Agarwal, Tarique Zaman, E Murat Tuzcu, et al.
Clinical Cardiology|July 30, 2024
Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes TrialAbhayjit Singh, Luke J Laffin, Ashish Sarraju, et al.
Journal of Cardiovascular Pharmacology|December 23, 2004
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury modelKai Wang, Khaldoun Tarakji, Zhongmin Zhou, et al.
American Heart Journal|August 9, 2005
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trialSorin J Brener, A Michael Lincoff, Eric R Bates, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 5, 2010
Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trialGiuseppe Ambrosio, Steven Steinhubl, Paolo Gresele, et al.
Chest|February 9, 2012
Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesPer Olav Vandvik, A Michael Lincoff, Joel M Gore, et al.
Pageof 36

Showing results (181-190 of 353) with videos related to

Sort By:
Pageof 36
JAMA Network Open|October 27, 2023
Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical TrialKarol M Pencina, Thomas G Travison, Andrew S Artz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2002
Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human studyEli I Lev, Jonathan D Marmur, Milan Zdravkovic, et al.
The Journal of Clinical Endocrinology and Metabolism|January 11, 2024
Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement TherapyShalender Bhasin, Stuart Seidman, Thomas G Travison, et al.
Circulation|November 26, 2009
Smoking, clopidogrel, and mortality in patients with established cardiovascular diseaseJeffrey S Berger, Deepak L Bhatt, Steven R Steinhubl, et al.
The American Journal of Cardiology|May 3, 2011
Comparison of outcomes of unprotected left main versus multivessel coronary artery interventionsShikhar Agarwal, Tarique Zaman, E Murat Tuzcu, et al.
Clinical Cardiology|July 30, 2024
Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes TrialAbhayjit Singh, Luke J Laffin, Ashish Sarraju, et al.
Journal of Cardiovascular Pharmacology|December 23, 2004
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury modelKai Wang, Khaldoun Tarakji, Zhongmin Zhou, et al.
American Heart Journal|August 9, 2005
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trialSorin J Brener, A Michael Lincoff, Eric R Bates, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 5, 2010
Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trialGiuseppe Ambrosio, Steven Steinhubl, Paolo Gresele, et al.
Chest|February 9, 2012
Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesPer Olav Vandvik, A Michael Lincoff, Joel M Gore, et al.
Pageof 36